查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1950528

週边血管介入器械市场（按器械类型、技术、应用、最终用户和分销管道划分），全球预测（2026-2032年）

Peripheral Vascular Interventional Devices Market by Device Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，週边血管介入器材市场规模将达到 15.2 亿美元，到 2026 年将成长至 15.7 亿美元，到 2032 年将达到 21 亿美元，年复合成长率为 4.68%。

关键市场统计数据
基准年 2025 15.2亿美元
预计年份：2026年 15.7亿美元
预测年份 2032 21亿美元
复合年增长率 (%) 4.68%

全面介绍週边介入器材：重点关注临床驱动因素、手术流程变革、新兴技术、健保报销趋势与产业策略挑战

週边介入器材在现代心血管治疗中发挥核心作用，包括动脉和静脉疾病的血管内治疗、透析通路维护以及跨多个专科的栓塞控制。器械工程和手术技术的进步已使许多介入治疗从开放性手术转向微创、影像引导的方式，重新定义了临床路径和相关人员的期望。临床医师越来越重视那些兼具疗效、缩短手术时间、降低併发症发生率以及适用于门诊环境的解决方案。

重塑週边介入治疗的关键变革包括设备创新、影像和机器人技术、数位整合、门诊转型以及供应链演进。

週边血管治疗领域正经历变革性的转变，其驱动因素包括：技术成熟、手术向门诊转移以及数位医疗融入介入工作流程。器械创新不再局限于材料和设计的渐进式改进，而是扩展到系统层面的提升，例如整合成像、导航辅助和辅助技术，从而降低对操作者的依赖性并减少手术操作的差异性。这些进步正加速被重视可预测临床结果和高效能个案管理的介入医师所接受。

评估2025年美国关税对週边血管器械供应链、定价、采购和商业化策略的累积经济和营运影响

2025年美国关税政策的实施，为週边血管器材生态系统中的製造商、医疗系统和经销商的运作引入了一个新的变数。进口零件和成品器械关税导致成本上升，迫使供应商重新评估其筹资策略，在采购合约中实施额外的成本控制措施，并探索其他製造地。这些趋势将对采购週期产生即时影响，并对产品系列决策产生长期影响。

详细的細項分析揭示了设备类型、应用领域、最终用户环境、技术变体和分销管道选择如何影响临床采用和采购趋势。

对市场区隔的深入理解有助于明确临床需求、技术能力和商业性机会之间的交集。依器械类型划分，市场涵盖动脉粥状硬化斑块切除术装置、球囊导管、栓塞剂、栓塞保护装置、下腔静脉滤器和支架。在动脉粥状硬化斑块切除术装置中，定向斑块动脉粥状硬化斑块切除术装置、雷射斑块动脉粥状硬化斑块切除术装置、轨道动脉粥状硬化斑块切除术装置和旋转动脉粥状硬化斑块切除术装置等亚型，分别针对特定的病变形态和临床医生的偏好，从而影响资本设备决策和临床培训需求。球囊导管分为药物涂层球囊导管和普通球囊导管，药物涂层球囊导管通常用于血管再阻塞风险高的区域或药物输送可减少再次介入治疗的区域。栓塞剂分为栓塞弹簧圈、栓塞颗粒和液体栓塞剂，每种栓塞剂都适用于不同的解剖标靶和栓塞策略。另一方面，栓塞保护装置依手术入路和栓塞风险分为远端栓塞保护装置和近端栓塞保护装置。下腔静脉滤器分为永久性滤网和可回收滤网。支架则分为裸金属支架和药物释放型支架，这反映了长期通畅性和血管再阻塞控制之间不同的权衡。

美洲、欧洲、中东和非洲以及亚太地区的关键区域趋势将影响采用模式、法规结构、製造在地化和市场进入途径。

区域趋势对週边血管器械的监管预期、采购惯例和创新路径有显着影响。在美洲，先进的医保报销体系和成熟的介入性心臟病学及放射学生态系统支援新型器械的快速应用。同时，门诊手术中心的兴起推动了对紧凑高效系统和可靠的上市后证据的需求，以确保对支付方和医疗管理机构课责。北美临床医生重视临床结果数据和手术效率，采购团队通常优先考虑供应商的可靠性和全面培训项目。

为医疗器材公司提供策略竞争考察，重点在于创新管线、伙伴关係、在地化生产、售后服务，以及透过临床证据和结果实现差异化。

医疗设备製造商之间的竞争围绕着三个相互依存的关键挑战：差异化的临床性能、可扩展的生产能力和一体化的商业性支援。主要企业正加大对稳健的临床项目的投入，以产生结果数据，从而支持监管核准和与支付方的谈判；同时，透过对医生培训和手术支持的补充性投资，降低实施风险。与影像、导航和数位医疗服务提供者的合作，能够优化手术方案规划和长期结果监测，从而提升产品价值。

为行业领导者提供实用建议，使其研发、生产弹性、定价、证据生成和商业策略与不断变化的临床和政策环境保持一致。

致力于在周边血管介入治疗领域中保持并扩大市场份额的行业领导者必须系统性地采取策略行动，优先考虑临床价值、营运柔软性和商业性敏捷性。首先，他们必须将研发资源集中在能够降低再次介入治疗率和手术复杂性的技术，并辅以严谨的临床试验，以评估短期疗效和长期血管健康状况。这些证据将有助于医保报销谈判，并推动相关技术在医院和门诊的普及应用。

采用透明的调查方法，包括识别一手和二手资料来源、临床医生访谈、监管分析、供应链图谱绘製以及三角验证技术，以检验结论。

本执行摘要的研究整合了多方面的证据，以确保分析的严谨性和实际应用价值。主要依据包括对介入临床医生、采购人员和器械工程师的结构化访谈，以及对同行评审的临床文献、监管申报文件和操作指南文件的审查。二级资讯来源依据包括器械相关的技术文献和製造商披露的信息，以及与临床试验註册库和专业学会指南的一致性。

策略性结论整合了临床趋势、技术转折点、监管影响以及积极的商业规划和跨职能协作的必要性。

週边介入器材市场环境的特征是创新加速、临床实践不断变化，以及对价值和价值链韧性的日益重视。降低血管再阻塞、减少栓塞併发症和实现门诊治疗等临床需求正在影响产品开发的优先事项和商业性合作策略。同时，政策变化和贸易趋势也提升了生产柔软性和供应商多元化的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 週边血管介入器械市场（依器械类型划分）

  • 动脉粥状硬化斑块切除术装置
    • 定向斑块动脉粥状硬化斑块切除术装置
    • 雷射动脉动脉粥状硬化斑块切除术装置
    • 轨道动脉动脉粥状硬化斑块切除术装置
    • 旋转式动脉粥状硬化斑块切除术装置
  • 球囊导管
    • 药物涂层球囊
    • 一般球囊导管
  • 栓塞剂
    • 栓塞线圈
    • 栓塞颗粒
    • 液态栓塞剂
  • 栓塞保护装置
    • 远端栓塞保护装置
    • 近端栓塞保护装置
  • IVC过滤器
    • 永久性下腔静脉滤器
    • 可回收IVC过滤器
  • 支架
    • 裸金属
    • 药物释放型型

9. 按技术分類的周边血管介入器材市场

  • 裸金属
  • 生物可吸收
  • 药物包衣

第十章 依应用分類的周边血管介入器材市场

  • 血液透析通路
    • 动静脉瘻管的维护
    • 移植维持
  • 周边动脉疾病
    • 严重肢体缺血
    • 间歇性跛行
  • 静脉疾病
    • 慢性静脉功能不全
    • 深层静脉栓塞症
    • 静脉曲张

第十一章 週边血管介入器材市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章 週边血管介入器械市场（依分销管道划分）

  • 直销
  • 批发的

13. 週边血管介入器材市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 週边血管介入器材市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国週边血管介入器材市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国週边血管介入器材市场

第十七章：中国週边血管介入器材市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • Cordis Corporation
  • Endologix, Inc.
  • InspireMD, Inc.
  • iVascular SLU
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Philips Healthcare
  • Shockwave Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-4F7A6D4FD8BF

The Peripheral Vascular Interventional Devices Market was valued at USD 1.52 billion in 2025 and is projected to grow to USD 1.57 billion in 2026, with a CAGR of 4.68%, reaching USD 2.10 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.52 billion
Estimated Year [2026] USD 1.57 billion
Forecast Year [2032] USD 2.10 billion
CAGR (%) 4.68%

Comprehensive introduction to peripheral vascular interventional devices highlighting clinical drivers, procedural shifts, emerging technologies, reimbursement dynamics, and strategic industry challenges

Peripheral vascular interventional devices occupy a central role in contemporary cardiovascular care, spanning endovascular therapies for arterial and venous disease, dialysis access maintenance, and embolic control across multiple specialties. Advances in device engineering and procedural techniques have shifted many interventions from open surgery to minimally invasive, image-guided approaches, thereby redefining clinical pathways and stakeholder expectations. Clinicians increasingly favor solutions that combine efficacy with shorter procedural times, lower complication rates, and compatibility with outpatient settings.

Demographic and epidemiologic trends have amplified clinical demand, while payers and health systems emphasize value through outcomes measurement and cost containment. In this environment, device developers must reconcile stringent regulatory requirements, evolving reimbursement criteria, and growing expectations for robust real-world evidence. At the same time, innovation cycles have accelerated, with manufacturers iterating on materials, coatings, and delivery systems to address restenosis, embolization risk, and long-term vessel integrity.

Consequently, strategic decision-makers require a consolidated view that integrates clinical drivers, technology trajectories, and commercial imperatives. This introduction frames the subsequent analysis by situating current device modalities within procedural workflows, highlighting the intersection of clinical need and engineering response, and underscoring the importance of cross-functional alignment between clinical affairs, regulatory, market access, and commercial teams.

Critical transformative shifts reshaping peripheral vascular interventions including device innovation, imaging and robotics, digital integration, outpatient migration, and supply chain evolution

The peripheral vascular landscape is undergoing transformative shifts driven by converging forces: technology maturation, procedural migration to outpatient settings, and the integration of digital health into interventional workflows. Device innovation now extends beyond incremental improvements to materials and designs; it encompasses system-level enhancements such as integrated imaging, navigation aids, and adjunctive technologies that reduce operator dependence and procedural variability. These developments accelerate adoption among interventionalists who prioritize predictable clinical outcomes and streamlined case management.

Simultaneously, there is a clear movement toward reducing patient length of stay and expanding case volumes in ambulatory settings. This shift pressures manufacturers to offer compact, user-friendly systems with simplified logistics and strong training support. Digital tools that facilitate remote proctoring, procedural analytics, and longitudinal outcomes tracking are increasingly embedded within commercial models, enabling manufacturers to demonstrate value beyond the point of sale.

Finally, supply chain resilience and manufacturing localization have risen on the strategic agenda. Recent disruptions have prompted industry leaders to reassess sourcing strategies, diversify supplier bases, and consider nearshoring for critical components. Taken together, these shifts redefine competitive boundaries and create windows of opportunity for organizations that can integrate clinical efficacy, operational simplicity, and commercial flexibility into coherent product and market strategies.

Assessment of the cumulative economic and operational impacts of United States tariffs in 2025 on peripheral vascular device supply chains, pricing, sourcing, and commercialization strategies

The imposition of tariffs by the United States in 2025 introduced a new variable into the operational calculus for manufacturers, health systems, and distributors across the peripheral vascular device ecosystem. Tariff-driven cost increases for imported components and finished devices have compelled suppliers to re-evaluate sourcing strategies, layer additional cost-control measures into procurement contracts, and explore alternative manufacturing footprints. These dynamics have immediate implications for procurement cycles and longer-term impacts on product portfolio decisions.

Providers and group purchasing organizations have responded by prioritizing supplier reliability and total-cost-of-ownership analysis, taking into account tariff exposure and logistics volatility. Some manufacturers accelerated efforts to localize production or qualify secondary suppliers in tariff-insulated jurisdictions to preserve pricing competitiveness. Simultaneously, distribution partners adapted inventory management practices to buffer supply for high-acuity devices while seeking contractual protections to manage price fluctuations.

From a strategic perspective, tariffs intensified conversations around modular design and component commonality to reduce dependence on tariff-affected parts. Clinical affairs teams collaborated more closely with supply chain and commercial functions to align product introductions with procurement realities, and regulatory teams assessed the implications of manufacturing shifts on device registrations. Overall, tariffs acted as a catalyst for operational realignment, prompting agile responses that emphasized flexibility, supplier diversification, and closer alignment between manufacturing choices and commercial channels.

In-depth segmentation insights revealing how device type, application area, end user setting, technology variants, and distribution channel choices dictate clinical adoption and procurement dynamics

A granular understanding of segmentation provides clarity about where clinical need, technology capability, and commercial opportunity intersect. Based on Device Type, the landscape encompasses Atherectomy Devices, Balloon Catheters, Embolic Agents, Embolic Protection Devices, IVC Filters, and Stents. Within Atherectomy Devices, the subtypes Directional Atherectomy Devices, Laser Atherectomy Devices, Orbital Atherectomy Devices, and Rotational Atherectomy Devices each address specific lesion morphologies and operator preferences, influencing capital equipment decisions and clinical training requirements. Balloon Catheters distinguish between Drug Coated Balloons and Plain Balloon Catheters, with drug-coated options often positioned where restenosis risk is elevated and where drug delivery can reduce repeat interventions. Embolic Agents are categorized into Embolic Coils, Embolic Particles, and Liquid Embolics, each suited to distinct anatomical targets and embolization strategies, while Embolic Protection Devices are split between Distal Embolic Protection Devices and Proximal Embolic Protection Devices depending on procedural access and embolic risk profile. IVC Filters appear as Permanent IVC Filters and Retrievable IVC Filters, and Stents are characterized as Bare Metal and Drug Eluting, reflecting divergent trade-offs between long-term patency and restenosis management.

Based on Application, treatments address Hemodialysis Access, Peripheral Arterial Disease, and Venous Disease. Hemodialysis Access subdivides into AV Fistula Maintenance and Graft Maintenance, each with different failure modes and device requirements. Peripheral Arterial Disease includes Critical Limb Ischemia and Intermittent Claudication, where treatment goals and acceptable risk thresholds differ markedly. Venous Disease covers Chronic Venous Insufficiency, Deep Vein Thrombosis, and Varicose Veins, which call for distinct therapeutic approaches and device attributes.

Based on End User, utilization patterns diverge across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics, shaping purchasing cycles, capital investment decisions, and service-level agreements. Based on Technology, choices among Bare Metal, Bioabsorbable, and Drug Coated materials influence clinical positioning and regulatory pathways. Finally, Based on Distribution Channel, the dichotomy between Direct Sales and Distributor Sales governs go-to-market complexity, margins, and post-sale service commitments. Synthesizing these segments reveals that device adoption mirrors clinical nuance: devices that address high-acuity, specialized anatomy often require hospital-based adoption supported by training and capital investments, whereas simpler or lower-cost interventions migrate more readily to ambulatory environments. Likewise, technology choices such as drug-coating or bioabsorbability drive evidence generation needs, while distribution decisions affect margin structures and customer intimacy.

Key regional dynamics across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence adoption patterns, regulatory frameworks, manufacturing localization, and market access pathways

Regional dynamics materially influence regulatory expectations, procurement practices, and innovation pathways for peripheral vascular devices. In the Americas, advanced reimbursement frameworks and a mature interventional cardiology and radiology ecosystem support rapid uptake of novel devices, while the rise of Ambulatory Surgical Centers accelerates demand for compact, high-efficiency systems and robust post-market evidence to satisfy payers and administrators. North American clinicians place a premium on clinical outcomes data and procedural efficiency, and procurement teams often prioritize supplier reliability and integrated training programs.

In Europe, Middle East & Africa, heterogeneous healthcare systems and varied reimbursement models create a patchwork of adoption rates. Regulatory harmonization efforts coexist with country-specific procurement practices, prompting manufacturers to tailor market access strategies by jurisdiction. Health systems with constrained budgets emphasize cost-effectiveness and multi-stakeholder value demonstration, while some countries in the region serve as centers of clinical excellence that influence broader practice patterns.

Asia-Pacific presents a dual narrative of rapid demand growth in urban centers alongside persistent affordability and access challenges in lower-income areas. Regional manufacturing ambitions and government incentives have encouraged local production, which in turn affects pricing dynamics and product customization. Clinical practice differences, disease prevalence patterns, and evolving regulatory frameworks make Asia-Pacific a focal point for incremental innovation that balances cost containment with performance. Across all regions, cross-border collaboration and data sharing increasingly shape clinical adoption and regulatory submissions, underscoring the value of region-specific strategies that account for reimbursement, provider preferences, and manufacturing considerations.

Strategic competitive insights into device companies focusing on innovation pipelines, partnerships, manufacturing localization, aftermarket services, and differentiation through clinical evidence and outcomes

Competitive dynamics among device companies center on three interdependent imperatives: differentiated clinical performance, scalable manufacturing, and integrated commercial support. Leading organizations increasingly invest in robust clinical programs that generate outcomes data for regulatory clearance and payer negotiation, while complementary investments in physician training and procedural support help to de-risk adoption. Partnerships with imaging, navigation, and digital health providers extend product value by enabling better procedural planning and long-term outcomes monitoring.

Manufacturing strategy is a second axis of differentiation. Companies that pursue a diversified supplier network or localized production can insulate customers from supply disruption and tariff exposure, thereby strengthening commercial credibility. At the same time, investments in modular platforms and component commonality reduce time-to-market for incremental innovations and improve cost efficiency.

A third strategic focus is aftermarket services and value-added offerings. Extended warranties, outcome-based contracting pilots, and bundled delivery models are increasingly used to create stickiness with healthcare systems. Competitive positioning also reflects portfolio breadth: firms that can offer complementary products across atherectomy, stenting, and embolic control benefit from cross-sell opportunities and stronger system-level value propositions. Ultimately, success depends on aligning clinical evidence generation, operational resilience, and commercial models to meet the nuanced needs of providers and payers.

Actionable recommendations for industry leaders to align research and development, manufacturing resilience, pricing, evidence generation, and commercial strategies with evolving clinical and policy landscapes

Industry leaders seeking to sustain and expand their footprint in peripheral vascular interventions should pursue a coordinated set of strategic actions that prioritize clinical value, operational flexibility, and commercial agility. First, concentrate R&D efforts on technologies that demonstrably reduce repeat interventions and lower procedural complexity, and pair those investments with rigorous clinical programs that capture both short-term efficacy and long-term vessel integrity. This evidence will support reimbursement discussions and facilitate adoption in both hospital and ambulatory settings.

Second, diversify manufacturing and supplier relationships to reduce exposure to trade policy shocks and logistical disruption. Where feasible, qualify regional manufacturing partners and adopt component standardization to streamline regulatory filings and shorten supply chains. Third, evolve commercial models to reflect customer needs: invest in training and remote proctoring to accelerate physician comfort with new devices, and consider outcome-based contracting in select markets to align incentives with health systems.

Fourth, refine distribution strategies by balancing direct sales presence where clinical complexity demands deep engagement with distributor partnerships in geographies where a broad footprint and logistics capability matter more. Finally, integrate digital tools that enhance procedural planning and post-procedural follow-up, using data to demonstrate value to payers and to support quality improvement initiatives. Prioritizing these actions will enable organizations to navigate structural shifts while delivering measurable clinical and economic value.

Transparent research methodology describing primary and secondary data sources, clinician interviews, regulatory analysis, supply chain mapping, and triangulation techniques used to validate conclusions

The research underlying this executive summary synthesizes multiple evidence streams to ensure analytical rigor and practical relevance. Primary inputs include structured interviews with interventional clinicians, procurement leaders, and device engineers, combined with a review of peer-reviewed clinical literature, regulatory filings, and procedural guidance documents. Secondary sources included device-specific technical literature and manufacturer disclosures, which were cross-checked against clinical trial registries and professional society guidelines for consistency.

Analysts employed triangulation techniques to reconcile divergent perspectives and to validate thematic findings. Supply chain and manufacturing assessments relied on supplier audits, trade flow analyses, and discussions with logistics partners to evaluate exposure to policy changes and operational vulnerabilities. Commercial insights were grounded in interviews with hospital purchasing officers, ambulatory surgical center administrators, and distribution channel partners to capture differences in procurement cycles and service expectations.

Quality control measures included independent peer review by clinicians and subject-matter experts, sensitivity testing of strategic assumptions, and explicit documentation of limitations. Where information gaps existed, analysts noted uncertainty and recommended targeted primary research. Ethical considerations guided the handling of proprietary information and clinician disclosures, ensuring that conclusions reflect a balanced and verifiable interpretation of available evidence.

Strategic conclusion synthesizing clinical trends, technological inflection points, regulatory implications, and the imperative for proactive commercial planning and cross-functional alignment

The landscape for peripheral vascular interventional devices is characterized by accelerating innovation, shifting care settings, and heightened scrutiny around value and supply chain resilience. Clinical demands for devices that reduce restenosis, limit embolic complications, and enable outpatient care are shaping product development priorities and commercial engagement strategies. At the same time, policy changes and trade dynamics have elevated the importance of manufacturing flexibility and supplier diversification.

For stakeholders across the value chain, the imperative is to translate clinical differentiation into demonstrable economic value while maintaining operational agility. Organizations that successfully integrate robust clinical evidence, localized or diversified manufacturing, and customer-centric commercial models will be best positioned to capture opportunities as procedural volumes and care models evolve. Cross-functional collaboration among clinical affairs, regulatory, supply chain, and commercial teams is no longer optional; it is a strategic necessity.

In closing, the industry stands at an inflection point where deliberate alignment between product innovation and pragmatic commercialization can accelerate adoption and improve patient outcomes. The path forward requires disciplined evidence generation, strategic operational choices, and a sustained focus on delivering measurable value to providers and payers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Interventional Devices Market, by Device Type

  • 8.1. Atherectomy Devices
    • 8.1.1. Directional Atherectomy Devices
    • 8.1.2. Laser Atherectomy Devices
    • 8.1.3. Orbital Atherectomy Devices
    • 8.1.4. Rotational Atherectomy Devices
  • 8.2. Balloon Catheters
    • 8.2.1. Drug Coated Balloons
    • 8.2.2. Plain Balloon Catheters
  • 8.3. Embolic Agents
    • 8.3.1. Embolic Coils
    • 8.3.2. Embolic Particles
    • 8.3.3. Liquid Embolics
  • 8.4. Embolic Protection Devices
    • 8.4.1. Distal Embolic Protection Devices
    • 8.4.2. Proximal Embolic Protection Devices
  • 8.5. IVC Filters
    • 8.5.1. Permanent IVC Filters
    • 8.5.2. Retrievable IVC Filters
  • 8.6. Stents
    • 8.6.1. Bare Metal
    • 8.6.2. Drug Eluting

9. Peripheral Vascular Interventional Devices Market, by Technology

  • 9.1. Bare Metal
  • 9.2. Bioabsorbable
  • 9.3. Drug Coated

10. Peripheral Vascular Interventional Devices Market, by Application

  • 10.1. Hemodialysis Access
    • 10.1.1. AV Fistula Maintenance
    • 10.1.2. Graft Maintenance
  • 10.2. Peripheral Arterial Disease
    • 10.2.1. Critical Limb Ischemia
    • 10.2.2. Intermittent Claudication
  • 10.3. Venous Disease
    • 10.3.1. Chronic Venous Insufficiency
    • 10.3.2. Deep Vein Thrombosis
    • 10.3.3. Varicose Veins

11. Peripheral Vascular Interventional Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Peripheral Vascular Interventional Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Peripheral Vascular Interventional Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Peripheral Vascular Interventional Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peripheral Vascular Interventional Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Peripheral Vascular Interventional Devices Market

17. China Peripheral Vascular Interventional Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AngioDynamics, Inc.
  • 18.7. Becton, Dickinson and Company
  • 18.8. BIOTRONIK SE & Co. KG
  • 18.9. Boston Scientific Corporation
  • 18.10. C.R. Bard, Inc.
  • 18.11. Cordis Corporation
  • 18.12. Endologix, Inc.
  • 18.13. InspireMD, Inc.
  • 18.14. iVascular S.L.U.
  • 18.15. Lepu Medical Technology Co., Ltd.
  • 18.16. Medtronic plc
  • 18.17. Merit Medical Systems, Inc.
  • 18.18. MicroPort Scientific Corporation
  • 18.19. Penumbra, Inc.
  • 18.20. Philips Healthcare
  • 18.21. Shockwave Medical, Inc.
  • 18.22. Teleflex Incorporated
  • 18.23. Terumo Corporation
  • 18.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED BALLOONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED BALLOONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED BALLOONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PLAIN BALLOON CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PLAIN BALLOON CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PLAIN BALLOON CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PARTICLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PARTICLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PARTICLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY LIQUID EMBOLICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTAL EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTAL EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTAL EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PROXIMAL EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PROXIMAL EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PROXIMAL EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERMANENT IVC FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERMANENT IVC FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERMANENT IVC FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY RETRIEVABLE IVC FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY RETRIEVABLE IVC FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY RETRIEVABLE IVC FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AV FISTULA MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AV FISTULA MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AV FISTULA MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GRAFT MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GRAFT MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GRAFT MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY INTERMITTENT CLAUDICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY INTERMITTENT CLAUDICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY INTERMITTENT CLAUDICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY CHRONIC VENOUS INSUFFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VARICOSE VEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VARICOSE VEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VARICOSE VEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY IVC FILTERS, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY HEMODIALYSIS ACCESS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY VENOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN PERIPHERAL VASCULAR INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (U